PLASMA IDOL, SOLUBLE LDLR AND PCSK9 LEVELS AS POTENTIAL BIOMARKERS OF FAMILIAL HYPERCHOLESTEROLEMIA IN CHILDREN

被引：0
|
作者：
Girona, J. [1 ]
Rodriguez-Borjabad, C. [2 ]
Ibarretxe, D. [2 ]
Heras, M. [1 ]
Amigo, N. [3 ]
Feliu, A. [4 ]
Masana, L. [1 ,2 ]
Plana, N. [2 ]
机构：
[1] URV, CIBERDEM, IISPV, Res Unit Lipids & Atherosclerosis, Reus, Spain
[2] URV, St Joan Univ Hosp, CIBERDEM, IISPV,Vasc Med & Metab Unit, Reus, Spain
[3] URV, CIBERDEM, IISPV, Biosfer Teslab, Reus, Spain
[4] Univ Rovira & Virgili, IISPV, Pediat Res Unit, Reus, Spain
来源：
ATHEROSCLEROSIS | 2018年 / 275卷
关键词：
D O I：
10.1016/j.atherosclerosis.2018.06.051
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAG3.3
引用
收藏
页码：E22 / E22
页数：1
相关论文
共 50 条
  • [1] Plasma levels of PCSK9 and phenotypic variability in familial hypercholesterolemia
    Huijgen, R.
    Fouchier, S. W.
    Denoun, M.
    Hutten, B. A.
    Vissers, M. N.
    Lambert, G.
    Kastelein, J. J. P.
    JOURNAL OF LIPID RESEARCH, 2012, 53 (05) : 979 - 983
  • [2] CHARACTERIZATION OF THE EFFECTS OF FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS IN LDLR ON PCSK9 BINDING
    Deng, Shijun
    Alabi, Adekunle
    Zhang, Dawei
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 55 - 55
  • [3] The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia
    Meshkov, Alexey
    Ershova, Alexandra
    Kiseleva, Anna
    Zotova, Evgenia
    Sotnikova, Evgeniia
    Petukhova, Anna
    Zharikova, Anastasia
    Malyshev, Pavel
    Rozhkova, Tatyana
    Blokhina, Anastasia
    Limonova, Alena
    Ramensky, Vasily
    Divashuk, Mikhail
    Khasanova, Zukhra
    Bukaeva, Anna
    Kurilova, Olga
    Skirko, Olga
    Pokrovskaya, Maria
    Mikova, Valeriya
    Snigir, Ekaterina
    Akinshina, Alexsandra
    Mitrofanov, Sergey
    Kashtanova, Daria
    Makarov, Valentin
    Kukharchuk, Valeriy
    Boytsov, Sergey
    Yudin, Sergey
    Drapkina, Oxana
    GENES, 2021, 12 (01) : 1 - 17
  • [4] Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia
    Pisciotta, Livia
    Oliva, Claudio Priore
    Cefalu, Angelo Baldassare
    Noto, Davide
    Bellocchio, Antonella
    Fresa, Raffaele
    Cantafora, Alfredo
    Patel, Dilip
    Averna, Maurizio
    Tarugi, Patrizia
    Calandra, Sebastiano
    Bertolini, Stefano
    ATHEROSCLEROSIS, 2006, 186 (02) : 433 - 440
  • [5] PCSK9 IN FAMILIAL HYPERCHOLESTEROLEMIA (FH)
    Lambert, G.
    Rye, K. -A.
    Burnett, J.
    Barter, P.
    Marais, D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 31 - 31
  • [6] PCSK9 Inhibitors for Familial Hypercholesterolemia
    Lenahan, Christy M.
    Harringtoon, Deedra
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2016, 12 (08): : 577 - 578
  • [7] Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India
    Reddy, Lakshmi Lavanya
    Shah, Swarup A. V.
    Ponde, Chandrashekhar K.
    Dalal, Jamshed J.
    Jatale, Raj G.
    Dalal, Reeta J.
    Rajani, Rajesh M.
    Pillai, Sudhir K.
    Vanjani, Chander V.
    Ashavaid, Tester F.
    JOURNAL OF HUMAN GENETICS, 2021, 66 (10) : 983 - 993
  • [8] Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients
    Hori, Mika
    Ohta, Naotaka
    Takahashi, Atsushi
    Masuda, Hiroaki
    Isoda, Rieko
    Yamamoto, Suguru
    Son, Cheol
    Ogura, Masatsune
    Hosoda, Kiminori
    Miyamoto, Yoshihiro
    Harada-Shiba, Mariko
    ATHEROSCLEROSIS, 2019, 289 : 101 - 108
  • [9] Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India
    Lakshmi Lavanya Reddy
    Swarup A. V. Shah
    Chandrashekhar K. Ponde
    Jamshed J. Dalal
    Raj G. Jatale
    Reeta J. Dalal
    Rajesh M. Rajani
    Sudhir K. Pillai
    Chander V. Vanjani
    Tester F. Ashavaid
    Journal of Human Genetics, 2021, 66 : 983 - 993
  • [10] PCSK9 inhibition in the management of familial hypercholesterolemia
    Ogura, Masatsune
    JOURNAL OF CARDIOLOGY, 2018, 71 (1-2) : 1 - 7
12345